Скачать или смотреть Is this the end of the road for me with Zepbound? My prescription coverage is changing!

If you're worried about GLP-1 prescription coverage, rising medication costs, or whether Zepbound will still be on your insurance formulary—this video is for you.

After CVS Caremark dropped Zepbound from its formularies and began favoring Wegovy, things began to shift. It's happening again, and this time, it’s personal. In this video, I share my real-time experience with potential GLP-1 coverage changes, what I've found out so far from my HR, and what it could mean for anyone taking Zepbound or other GLP-1 medications.

🔍 In this video, we cover:
✅ GLP-1 medication coverage updates (Zepbound vs. Wegovy)
✅ What happens when your GLP-1 is dropped from coverage
✅ CVS Caremark & Highmark policy changes
✅ How to navigate prior authorizations (PAs)
✅ Tips for open enrollment and protecting your prescription
✅ Personal experience and advice for GLP-1 users

📌 Helpful Links:
📺 Watch my original video on CVS dropping Zepbound in favor of Wegovy here:    • CVS Just Dropped Zepbound — Here’s What It...  

💬 Join the conversation!
Have you received a letter from your pharmacy or insurance about your GLP-1 coverage? Drop a comment below and let’s support each other through the chaos.

🔔 Don’t forget to subscribe for real-time updates on GLP-1 news, user experiences, and tips for navigating healthcare changes.

Disclaimer: The content shared in this video is based on my personal experience with Zepbound (tirzepatide) and informal research of GLP-1 medications. I am not a medical professional, and the information provided here is for informational purposes only. Always consult with a healthcare provider before starting any new medication or treatment. Results and side effects can vary from person to person.

#GLP1 #Zepbound #Wegovy #CVSCaremark #PrescriptionCoverage #OpenEnrollment #MedicationCosts #PriorAuthorization #GLP1News #ZepboundCoverage #GLP1Alternatives #GLP1Experience